Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATVI Activision Blizzard	$94.42	$93.80	$70.94 ▼ $94.57	$74.29B	0.44	8.31 million shs	1 shs
COP ConocoPhillips	$92.75 -2.7%	$91.97	$79.88 ▼ $116.08	$120.53B	0.67	5.42 million shs	6.35 million shs
MSFT Microsoft	$524.11 -1.8%	$489.94	$344.79 ▼ $555.45	$3.97T	1.06	17.33 million shs	28.95 million shs
PFE Pfizer	$23.49 +0.9%	$24.36	$20.92 ▼ $31.32	$132.41B	0.52	38.02 million shs	51.29 million shs

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATVI Activision Blizzard	0.00%	0.00%	0.00%	0.00%	0.00%
COP ConocoPhillips	-2.70%	-2.32%	-1.66%	+1.41%	-16.59%
MSFT Microsoft	-1.76%	+2.02%	+6.72%	+20.41%	+25.28%
PFE Pfizer	+0.95%	-5.22%	-7.23%	-2.89%	-23.08%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ATVI Activision Blizzard	0.7941 of 5 stars	0.0	0.0	2.5	2.1	0.0	1.7	0.6
COP ConocoPhillips	4.8694 of 5 stars	4.4	3.0	2.5	0.0	3.0	3.3	2.5
MSFT Microsoft	4.9432 of 5 stars	3.5	5.0	3.3	2.9	3.8	2.5	1.9
PFE Pfizer	4.952 of 5 stars	2.3	5.0	4.2	4.5	3.9	1.7	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATVI Activision Blizzard	0.00	N/A	N/A	N/A
COP ConocoPhillips	2.88	Moderate Buy	$121.33	30.82% Upside
MSFT Microsoft	2.94	Moderate Buy	$609.86	16.36% Upside
PFE Pfizer	2.50	Moderate Buy	$28.28	20.38% Upside

Current Analyst Ratings Breakdown

Latest COP, MSFT, PFE, and ATVI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/31/2025	MSFT Microsoft	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$530.00 ➝ $582.00
7/31/2025	MSFT Microsoft	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$600.00 ➝ $650.00
7/31/2025	MSFT Microsoft	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$600.00 ➝ $650.00
7/31/2025	MSFT Microsoft	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$550.00 ➝ $625.00
7/31/2025	MSFT Microsoft	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$600.00 ➝ $675.00
7/31/2025	MSFT Microsoft	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$600.00 ➝ $650.00
7/31/2025	MSFT Microsoft	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Outperform ➝ Sector Outperform	$500.00 ➝ $650.00
7/31/2025	MSFT Microsoft	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$525.00 ➝ $640.00
7/31/2025	MSFT Microsoft	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$600.00 ➝ $650.00
7/31/2025	MSFT Microsoft	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy	$580.00 ➝ $640.00
7/23/2025	COP ConocoPhillips	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Positive ➝ Positive	$114.00 ➝ $113.00

(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATVI Activision Blizzard	$8.71B	8.53	$3.38 per share	27.91	$24.59 per share	3.84
COP ConocoPhillips	$56.95B	2.06	$14.61 per share	6.35	$50.79 per share	1.83
MSFT Microsoft	$281.72B	13.83	$17.97 per share	29.16	$46.21 per share	11.34
PFE Pfizer	$63.63B	2.10	$4.40 per share	5.34	$15.62 per share	1.50

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATVI Activision Blizzard	$1.51B	$2.73	34.59	24.09	2.61	24.87%	14.87%	10.78%	N/A
COP ConocoPhillips	$9.25B	$7.87	11.79	10.49	2.48	16.02%	16.54%	8.64%	8/7/2025 (Estimated)
MSFT Microsoft	$88.14B	$13.64	38.42	35.65	2.39	36.15%	32.44%	18.20%	N/A
PFE Pfizer	$8.03B	$1.38	17.02	7.75	0.84	12.62%	20.33%	8.53%	8/5/2025 (Estimated)

Latest COP, MSFT, PFE, and ATVI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	COP ConocoPhillips	$1.41	N/A	N/A	N/A	$14.39 billion	N/A
8/5/2025	Q2 2025	PFE Pfizer	$0.57	N/A	N/A	N/A	$13.43 billion	N/A
7/30/2025	Q4 2025	MSFT Microsoft	$3.35	$3.65	+$0.30	$3.65	$73.79 billion	$76.44 billion
5/8/2025	Q1 2025	COP ConocoPhillips	$2.05	$2.09	+$0.04	$2.23	$15.74 billion	$16.18 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATVI Activision Blizzard	$0.99	1.05%	N/A	36.26%	1 Years
COP ConocoPhillips	$3.12	3.36%	N/A	39.64%	N/A
MSFT Microsoft	$3.32	0.63%	N/A	24.34%	23 Years
PFE Pfizer	$1.72	7.32%	N/A	124.64%	16 Years

Latest COP, MSFT, PFE, and ATVI Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/10/2025	MSFT Microsoft	quarterly	$0.83	0.71%	8/21/2025	8/21/2025	9/11/2025
6/25/2025	PFE Pfizer	quarterly	$0.43	7.08%	7/25/2025	7/25/2025	9/2/2025
5/9/2025	COP ConocoPhillips	quarterly	$0.78	3.5%	5/19/2025	5/19/2025	6/2/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATVI Activision Blizzard	0.17	4.66	4.66
COP ConocoPhillips	0.36	1.27	1.13
MSFT Microsoft	0.12	1.35	1.36
PFE Pfizer	0.64	1.26	0.96

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ATVI Activision Blizzard	81.93%
COP ConocoPhillips	82.36%
MSFT Microsoft	71.13%
PFE Pfizer	68.36%

Insider Ownership

Company	Insider Ownership
ATVI Activision Blizzard	1.08%
COP ConocoPhillips	0.24%
MSFT Microsoft	0.03%
PFE Pfizer	0.06%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ATVI Activision Blizzard	13,000	786.80 million	778.30 million	Optionable
COP ConocoPhillips	11,800	1.26 billion	1.26 billion	Optionable
MSFT Microsoft	228,000	7.43 billion	7.43 billion	Optionable
PFE Pfizer	81,000	5.69 billion	5.68 billion	Optionable

COP, MSFT, PFE, and ATVI Headlines

Recent News About These Companies

Aviso Wealth Management Reduces Stock Position in Pfizer Inc. (NYSE:PFE)

3 hours ago | marketbeat.com

Banco Santander S.A. Has $27.89 Million Stock Position in Pfizer Inc. (NYSE:PFE)

4 hours ago | marketbeat.com

PNC Financial Services Group Inc. Sells 411,806 Shares of Pfizer Inc. (NYSE:PFE)

4 hours ago | marketbeat.com

Jupiter Asset Management Ltd. Has $39.76 Million Stock Holdings in Pfizer Inc. (NYSE:PFE)

4 hours ago | marketbeat.com

Pfizer Inc. (NYSE:PFE) Shares Sold by Kazazian Asset Management LLC

4 hours ago | marketbeat.com

Pfizer Inc. (NYSE:PFE) Shares Purchased by LSV Asset Management

4 hours ago | marketbeat.com

Pfizer Inc. (NYSE:PFE) Shares Sold by Asset Planning Inc

4 hours ago | marketbeat.com

Pfizer (PFE) Shows Mixed Options Activity and Earnings Anticipation

August 1 at 5:52 PM | gurufocus.com

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

August 1 at 5:04 PM | fastcompany.comF

Pfizer’s New Study on Abrocitinib: A Potential Breakthrough for Pediatric Eczema

August 1 at 12:41 PM | tipranks.com

Pfizer’s New Study on PF-07934040: A Potential Game-Changer in Cancer Treatment?

August 1 at 12:41 PM | tipranks.com

Pfizer/BioNTech lose appeal to reverse Moderna’s COVID vaccine patent win in U.K.

August 1 at 12:22 PM | msn.com

Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q2 Earnings

August 1 at 11:05 AM | zacks.com

Moderna (MRNA) Wins Court Ruling Against Pfizer and BioNTech in Patent Dispute

August 1 at 9:01 AM | gurufocus.com

Pfizer Inc. (NYSE:PFE) Shares Purchased by Commerce Bank

August 1 at 6:20 AM | marketbeat.com

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

August 1 at 5:59 AM | reuters.com

Howland Capital Management LLC Sells 14,218 Shares of Pfizer Inc. (NYSE:PFE)

August 1 at 5:47 AM | marketbeat.com

US Bancorp DE Sells 563,335 Shares of Pfizer Inc. (NYSE:PFE)

August 1 at 5:47 AM | marketbeat.com

Pfizer (PFE) Dips More Than Broader Market: What You Should Know

August 1 at 2:19 AM | msn.com

The three-year shareholder returns and company earnings persist lower as Pfizer (NYSE:PFE) stock falls a further 6.1% in past week

August 1 at 2:19 AM | finance.yahoo.com

Should You Buy Pfizer (PFE) Stock Before August 5? Here's What History Says

August 1 at 2:19 AM | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

3 Analysts Set $600 Target Ahead of Microsoft Earnings
By Chris Markoch | July 15, 2025
View 3 Analysts Set $600 Target Ahead of Microsoft Earnings
Super Micro Computer: The Hidden Winner of Soaring Copper Tariffs
By Gabriel Osorio-Mazilli | July 11, 2025
View Super Micro Computer: The Hidden Winner of Soaring Copper Tariffs
Why Freeport-McMoRan Is The Copper King in a Tight Market
By Jeffrey Neal Johnson | July 7, 2025
View Why Freeport-McMoRan Is The Copper King in a Tight Market
Why Freeport-McMoRan Stock May Hit a New High After Earnings Beat
By Chris Markoch | July 25, 2025
View Why Freeport-McMoRan Stock May Hit a New High After Earnings Beat
Microsoft’s AI Bet Faces a Major Test This Earnings Season
By Chris Markoch | July 24, 2025
View Microsoft’s AI Bet Faces a Major Test This Earnings Season

COP, MSFT, PFE, and ATVI Company Descriptions

Activision Blizzard NASDAQ:ATVI

Activision Blizzard, Inc., together with its subsidiaries, develops and publishes interactive entertainment content and services in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through three segments: Activision, Blizzard, and King. It develops and distributes content and services on video game consoles, personal computers, and mobile devices, including subscription, full-game, and in-game sales, as well as by licensing software to third-party or related-party companies that distribute Activision and Blizzard products. The company also maintains a proprietary online gaming service, Battle.net that facilitates digital distribution of content, online social connectivity, and the creation of user-generated content. In addition, it operates esports leagues and offer digital advertising content; and provides warehousing, logistics, and sales distribution services to third-party publishers of interactive entertainment software, as well as manufacturers of interactive entertainment hardware products. The company's key product franchises include Call of Duty, World of Warcraft, Diablo, Hearthstone, Overwatch, Overwatch League, and Candy Crush. It serves retailers and distributors, including mass-market retailers, consumer electronics stores, discount warehouses, and game specialty stores through third-party distribution and licensing arrangements. The company was founded in 1979 and is headquartered in Santa Monica, California.

ConocoPhillips NYSE:COP

$92.75 -2.59 (-2.72%)

Closing price 08/1/2025 03:59 PM Eastern

Extended Trading

$92.68 -0.07 (-0.08%)

As of 08/1/2025 08:00 PM Eastern

ConocoPhillips explores for, produces, transports, and markets crude oil, bitumen, natural gas, liquefied natural gas (LNG), and natural gas liquids in the United States, Canada, China, Libya, Malaysia, Norway, the United Kingdom, and internationally. The company's portfolio includes unconventional plays in North America; conventional assets in North America, Europe, Asia, and Australia; global LNG developments; oil sands assets in Canada; and an inventory of global exploration prospects. ConocoPhillips was founded in 1917 and is headquartered in Houston, Texas.

Microsoft NASDAQ:MSFT

$524.11 -9.39 (-1.76%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$523.64 -0.47 (-0.09%)

As of 08/1/2025 07:59 PM Eastern

Microsoft Corporation develops and supports software, services, devices and solutions worldwide. The Productivity and Business Processes segment offers office, exchange, SharePoint, Microsoft Teams, office 365 Security and Compliance, Microsoft viva, and Microsoft 365 copilot; and office consumer services, such as Microsoft 365 consumer subscriptions, Office licensed on-premises, and other office services. This segment also provides LinkedIn; and dynamics business solutions, including Dynamics 365, a set of intelligent, cloud-based applications across ERP, CRM, power apps, and power automate; and on-premises ERP and CRM applications. The Intelligent Cloud segment offers server products and cloud services, such as azure and other cloud services; SQL and windows server, visual studio, system center, and related client access licenses, as well as nuance and GitHub; and enterprise services including enterprise support services, industry solutions, and nuance professional services. The More Personal Computing segment offers Windows, including windows OEM licensing and other non-volume licensing of the Windows operating system; Windows commercial comprising volume licensing of the Windows operating system, windows cloud services, and other Windows commercial offerings; patent licensing; and windows Internet of Things; and devices, such as surface, HoloLens, and PC accessories. Additionally, this segment provides gaming, which includes Xbox hardware and content, and first- and third-party content; Xbox game pass and other subscriptions, cloud gaming, advertising, third-party disc royalties, and other cloud services; and search and news advertising, which includes Bing, Microsoft News and Edge, and third-party affiliates. The company sells its products through OEMs, distributors, and resellers; and directly through digital marketplaces, online, and retail stores. The company was founded in 1975 and is headquartered in Redmond, Washington.

Pfizer NYSE:PFE

$23.49 +0.20 (+0.86%)

Closing price 08/1/2025 03:59 PM Eastern

Extended Trading

$23.52 +0.03 (+0.11%)

As of 08/1/2025 07:59 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time